Clinical Trials Logo

Healthy Volunteers clinical trials

View clinical trials related to Healthy Volunteers.

Filter by:

NCT ID: NCT03364686 Terminated - Healthy Volunteers Clinical Trials

Transfusion of Biotin-Labeled Red Blood Cells

Start date: September 16, 2019
Phase: Phase 2
Study type: Interventional

The purpose of this research is to evaluate the impact of genetic and biologic factors in blood donors on red blood cell storage stability after autologous transfusion over the different range of storage period of 5-7 days and 35-42 days in healthy volunteers.

NCT ID: NCT03362593 Terminated - Healthy Volunteers Clinical Trials

A 6-Part Study In Healthy Volunteers To Evaluate Safety, Tolerability and Uptake Of MEDI7219 in the Body When Given as Single and Multiple Doses

Start date: December 4, 2017
Phase: Phase 1
Study type: Interventional

This is a 6-part study to evaluate the safety, tolerability, and PK of MEDI7219 in healthy subjects. Parts A, B, C & E are the single-dose parts of the study. Parts D & F are the multiple ascending dose (MAD) parts of the study. The starting dose and formulation for Parts D & F will be selected from data emerging from Parts A, B and E. Enrollment of approximately 198 subjects is anticipated.

NCT ID: NCT03276728 Terminated - Heart Failure Clinical Trials

Study to Evaluate the Safety and Tolerability of AMG 986 in Healthy Volunteers and Heart Failure Patients

Start date: August 12, 2016
Phase: Phase 1
Study type: Interventional

To evaluate the safety and tolerability of ascending single (Part A) and ascending multiple (Part B) doses of AMG 986 in healthy adults and of ascending multiple oral doses of AMG 986 in heart failure patients (Part C).

NCT ID: NCT03206112 Terminated - Healthy Volunteers Clinical Trials

Loss of Depotentiation in Focal Dystonia

Start date: September 20, 2017
Phase:
Study type: Observational

Background Focal dystonia is a brain disorder. It affects a muscle or muscles in a specific part of the body. Researchers think it may be related to excessive training or practice. They want to know more about how much training might trigger focal dystonia. Objectives: To study why people develop focal dystonia. To study how brain plasticity changes with focal dystonia. Eligibility: People at least 18 years of age with focal dystonia. Healthy volunteers the same age are also needed. Design: Participants will be screened with a physical exam and questions. They may have blood and urine tests. Participants will have up to 3 testing visits. Participants will have small electrodes stuck on the skin on the hands or arms. Muscle activity will be recorded. Participants will have transcranial magnetic stimulation (TMS). A wire coil will be placed onto the scalp. A brief electrical current will pass through the coil. The current will create a magnetic field that affects brain activity. Participants may be asked to tense certain muscles or do simple actions during TMS. A nerve at the wrist will get weak electrical stimulation. The stimulation may be paired with TMS for very short times. Participants will receive repeated magnetic pulses. Participants will receive a total of 150 pulses during a 10-second period. An entire testing visit will last about 3 hours. ...

NCT ID: NCT03125434 Terminated - Healthy Volunteers Clinical Trials

Normative Dynamic & Magnetic Spine

NDMS
Start date: April 27, 2017
Phase: N/A
Study type: Interventional

This study aims to describe normal spinal musculoskeletal patterns in healthy adolescents and young adults by using static and dynamic measures. Static informations are obtained from full-spine stereoradiography for skeletal measures and from high-resolution spine muscle MRI for muscular data. Dynamics stability is calculated from 3D gait analysis.

NCT ID: NCT03039868 Terminated - Healthy Volunteer Clinical Trials

Use of Pap Smear Derived Cells to Analyze the Expression of SLC6A14 and GPR81 Genes

Start date: December 2016
Phase:
Study type: Observational

SLC6A14 may serve as a biomarker for cervical dysplasia or cervical cancer.

NCT ID: NCT03000686 Terminated - Healthy Volunteers Clinical Trials

Study of GSK2586881 on Acute Hypoxia and Exercise

Start date: May 17, 2017
Phase: Phase 1
Study type: Interventional

This study is conducted to examine how GSK2586881, a recombinant human ACE2 peptide, modulates the acute hypoxic pulmonary vasoconstriction (HPV) response in healthy volunteers. The study will be single-center, randomized, placebo-controlled and double blind (sponsor open). Subjects will be randomized to receive a single intravenous (IV) dose of GSK2586881 or placebo (saline) in a crossover design. The primary objective of the study is to evaluate the effect of a single IV dose of GSK2586881 on the HPV response in healthy volunteers during exercise under hypoxic conditions. Approximately 35 subjects will be enrolled for a maximum of 56 days.

NCT ID: NCT02958982 Terminated - Asthma Clinical Trials

Safety, Tolerability and Pharmacokinetics of Oral Doses of RP3128 of Rhizen Pharmaceuticals

Start date: November 3, 2016
Phase: Phase 1/Phase 2
Study type: Interventional

RP3128 is a calcium release activated calcium (CRAC) channel modulator. The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of single and multiple ascending dose(s) of RP3128 in healthy volunteers and to evaluate the effect on late phase asthmatic response to allergen challenge in patients with mild asthma.

NCT ID: NCT02932488 Terminated - Healthy Volunteers Clinical Trials

Cerebral Pharmacodynamic Effects of 5-HT1B Receptor Stimulation

Start date: September 2016
Phase: Phase 1
Study type: Interventional

The purpose of this study is to show that PET-MR imaging can be used for obtaining a pharmacodynamic profile of drugs. By using the 5-HT1B receptor as target we also aim to find effect areas and sizes of the 5-HT1B receptor agonist sumatriptan.

NCT ID: NCT02918266 Terminated - Healthy Volunteers Clinical Trials

TAK-071 Scopolamine-Induced Cognitive Impairment Study

Start date: November 21, 2016
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the effect of a single oral dose of TAK-071 on the attenuation of cognitive deficit induced by scopolamine as measured by Groton Maze Learning Test (GMLT) (total number of errors).